---
title: "IDEXX Laboratories Inc. Stock Underperforms Tuesday When Compared To Competitors"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293385573.md"
description: "IDEXX Laboratories Inc. (IDXX) shares fell 2.01% to $552.46 on Tuesday, underperforming the broader market and several competitors despite a positive trading session for major indices. This marks the third consecutive day of losses for IDEXX, which is now trading 28.25% below its 52-week high. Trading volume remained significantly below the 50-day average."
datetime: "2026-07-21T20:51:04.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293385573.md)
  - [en](https://longbridge.com/en/news/293385573.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293385573.md)
generator: "portal-rs"
---

# IDEXX Laboratories Inc. Stock Underperforms Tuesday When Compared To Competitors

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of IDEXX Laboratories Inc. (IDXX) slipped 2.01% to $552.46 Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 0.89% to 7,509.20 and the Dow Jones Industrial Average rising 0.74% to 52,224.64.

This was the stock's third consecutive day of losses.

IDEXX Laboratories Inc. closed 28.25% below its 52-week high of $769.98, which the company achieved on November 26th.

The stock underperformed when compared to some of its competitors Tuesday, as Johnson & Johnson (JNJ) rose 0.72% to $250.61, Medtronic PLC (MDT) fell 1.13% to $82.35, and Boston Scientific Corp. (BSX) fell 1.33% to $43.19.

Trading volume (409,292) remained 261,378 below its 50-day average volume of 670,670.

Data source: Dow Jones Market Data, FactSet. Data compiled July 21, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

07-21-26 1651ET

### Related Stocks

- [IDXX.US](https://longbridge.com/en/quote/IDXX.US.md)
- [.SPX.US](https://longbridge.com/en/quote/.SPX.US.md)
- [.DJI.US](https://longbridge.com/en/quote/.DJI.US.md)
- [JNJ.US](https://longbridge.com/en/quote/JNJ.US.md)
- [MDT.US](https://longbridge.com/en/quote/MDT.US.md)
- [BSX.US](https://longbridge.com/en/quote/BSX.US.md)
- [FDS.US](https://longbridge.com/en/quote/FDS.US.md)

## Related News & Research

- [Azimuth Capital Investment Management LLC Sells 12,103 Shares of IDEXX Laboratories, Inc. $IDXX](https://longbridge.com/en/news/298125911.md)
- [Stronger Q2 Results And Raised 2026 Outlook Could Be A Game Changer For IDEXX Laboratories (IDXX)](https://longbridge.com/en/news/298111178.md)
- [Trajan Wealth LLC Has $10.13 Million Stake in Johnson & Johnson $JNJ](https://longbridge.com/en/news/298127700.md)
- [Seilern Investment Management Ltd Purchases 16,729 Shares of IDEXX Laboratories, Inc. $IDXX](https://longbridge.com/en/news/295321407.md)
- [IDEXX Laboratories to Present at Stifel Conference and Announces 2026 Investor Day | IDXX Stock News](https://longbridge.com/en/news/286464576.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**